Daptomycin-induced rhabdomyolysis and acute liver injury

Scandinavian Journal of Infectious Diseases

Volumn 46, Issue 7, 2014, Pages 537-540

  King, S Travis ^a,b   Walker, Erica D ^b,c   Cannon, Colleen G ^b   Finley, Richard W ^b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Daptomycin; Drug induced; Hepatotoxicity; Obese; Rhabdomyolysis; Statin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMLODIPINE; ASPARTATE AMINOTRANSFERASE; CIPROFLOXACIN; CREATINE KINASE; CREATININE; DAPTOMYCIN; DOXYCYCLINE; GLIPIZIDE; METFORMIN; OLMESARTAN; SODIUM CHLORIDE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AFRICAN AMERICAN; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DEBRIDEMENT; DISEASE DURATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMERGENCY WARD; FEMALE; FLUID RESUSCITATION; FOLLOW UP; FOOT AMPUTATION; FOOT EDEMA; FOOT PAIN; FOOT RADIOGRAPHY; HUMAN; LIMB PAIN; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; MYALGIA; MYOGLOBINURIA; NECK PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; OUTPATIENT CARE; PAIN ASSESSMENT; RHABDOMYOLYSIS; SHOULDER PAIN; SOFT TISSUE INFECTION; TOXIC HEPATITIS; VIRUS INFECTION; WOUND CARE; WOUND DRAINAGE; WOUND HEALING IMPAIRMENT; WOUND IRRIGATION; BACTERIAL INFECTIONS; CHEMICALLY INDUCED; DRUG-INDUCED LIVER INJURY;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DAPTOMYCIN; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; MIDDLE AGED; RHABDOMYOLYSIS;

EID: 84902576735     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2014.901555     Document Type: Article

References (14)

1. Cubicin (daptomycin) injection [package insert]. L exington, MA: Cubist Pharmaceuticals;2013
2. Odero R O, Cleveland K O, Gelfand M S. R habdomyolysis and acute renal failure associated with the co-Administration of daptomycin and an HMG-CoA reductase inhibitor. J Antimicrob Chemother 2009;63:1299-300
3. Papadopoulos S, Ball AM, Liewer S E, Martin C A, Winstead PS, Murphy BS. Rhabdomyolysis during therapy with daptomycin. Clin Infect Dis 2006;42:e108-10
4. Echevarria K, Datta P, Cadena J, Lewis JS II. S evere myopathy and possible hepatotoxicity related to daptomycin. J Antimicrob Chemother 2005;55:599-600. (Pubitemid 40542612
5. Patel SJ, Samo T C, Suki WN. E arly-onset rhabdomyolysis related to daptomycin use. Int J Antimicrob Agents 2007;30:472-4. (Pubitemid 47505300
6. LiverTox. U nited States National Library of Medicine. Bethesda, MD: NLM;2014. Available at: Http://livertox.nih. gov/ (accessed 11 February 2014
7. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45. (Pubitemid 12149145
8. Maria V A, Victorino R M. D evelopment and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997;26:664-9. (Pubitemid 27392358
9. Kazory A, Dibadj K, Weiner ID. R habdomyolysis and acute renal failure in a patient treated with daptomycin. J Antimicrob Chemother 2006;57:578-9. (Pubitemid 43240217
10. Pai M P, Norenberg J P, Anderson T, Goade DW, Rodvold KA, Telepak RA, et al. Infl uence of morbid obesity on the single-dose pharmacokinetics of daptomycin. Antimicrob Agents Chemother 2007;51:2741-7. (Pubitemid 47206208
11. Bookstaver PB, Bland CM, Qureshi ZP, Faulkner-Fennell CM, Sheldon MA, Caulder CR, et al. Safety and effectiveness of daptomycin across a hospitalized obese population; results of a multicenter investigation in the southeastern United States. Pharmacotherapy 2013;33:1322-30
12. Abraham G, Finkelberg D, Spooner LM. D aptomycininduced acute renal and hepatic toxicity without rhabdomyolysis. Ann Pharmacother 2008;42:719-21. (Pubitemid 351619945
13. Colomba C, Rubino R, Siracusa L, Mazzola G, Titone L. Rhabdomyolysis associated with the co-Administration of daptomycin and pegylated interferon 〈-2b and ribavirin in a patient with hepatitis C. J Antimicrob Chemother 2012;67;249-50
14. Oleson FB, Berman CL, L i AP. A n evaluation of the P450 inhibition and induction potential of daptomycin in primary human hepatocytes. Chem Biol Interact 2004;150:137-47.